ATE141802T1 - Illudin-analoge, verwendet als antitumormittel - Google Patents
Illudin-analoge, verwendet als antitumormittelInfo
- Publication number
- ATE141802T1 ATE141802T1 AT90916968T AT90916968T ATE141802T1 AT E141802 T1 ATE141802 T1 AT E141802T1 AT 90916968 T AT90916968 T AT 90916968T AT 90916968 T AT90916968 T AT 90916968T AT E141802 T1 ATE141802 T1 AT E141802T1
- Authority
- AT
- Austria
- Prior art keywords
- illudin
- tumor agent
- analogues used
- analog
- subject
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229930190064 illudin Natural products 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000004565 tumor cell growth Effects 0.000 abstract 2
- QVMDIQLUNODCTG-UHFFFAOYSA-N (3'R)-3'r,6't-Dihydroxy-2',2',4',6'c-tetramethyl-2',3'-dihydro-spiro[cyclopropan-1,5'-inden]-7'-on Natural products CC1=C2C(O)C(C)(C)C=C2C(=O)C(C)(O)C11CC1 QVMDIQLUNODCTG-UHFFFAOYSA-N 0.000 abstract 1
- QVMDIQLUNODCTG-OCCSQVGLSA-N Illudin M Chemical class C12([C@@](C)(O)C(=O)C3=CC(C)(C)[C@H](O)C3=C2C)CC1 QVMDIQLUNODCTG-OCCSQVGLSA-N 0.000 abstract 1
- AKYKZQWKCBEJHI-UHFFFAOYSA-N Illudin S Natural products CC1=C2C(O)C(C)(CO)C=C2C(=O)C(O)C13CC3 AKYKZQWKCBEJHI-UHFFFAOYSA-N 0.000 abstract 1
- DDLLIYKVDWPHJI-RDBSUJKOSA-N Illudin S Chemical compound C12([C@@](C)(O)C(=O)C3=C[C@@](C)(CO)[C@H](O)C3=C2C)CC1 DDLLIYKVDWPHJI-RDBSUJKOSA-N 0.000 abstract 1
- DDLLIYKVDWPHJI-UHFFFAOYSA-N Lampterol Natural products CC1=C2C(O)C(C)(CO)C=C2C(=O)C(C)(O)C11CC1 DDLLIYKVDWPHJI-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41639589A | 1989-10-03 | 1989-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE141802T1 true ATE141802T1 (de) | 1996-09-15 |
Family
ID=23649800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90916968T ATE141802T1 (de) | 1989-10-03 | 1990-10-02 | Illudin-analoge, verwendet als antitumormittel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5439942A (de) |
| EP (1) | EP0565519B1 (de) |
| JP (1) | JPH05503077A (de) |
| AT (1) | ATE141802T1 (de) |
| AU (1) | AU6729590A (de) |
| CA (2) | CA2067365C (de) |
| DE (1) | DE69028320T2 (de) |
| DK (1) | DK0565519T3 (de) |
| ES (1) | ES2091249T3 (de) |
| IL (1) | IL95875A (de) |
| WO (1) | WO1991004754A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439936A (en) * | 1989-10-03 | 1995-08-08 | The Regents Of The University Of California | Method of treating certain tumors using illudin analogs |
| US5932553A (en) * | 1996-07-18 | 1999-08-03 | The Regents Of The University Of California | Illudin analogs useful as antitumor agents |
| US5723632A (en) * | 1996-08-08 | 1998-03-03 | Mgi Pharma, Inc. | Total synthesis of antitumor acylfulvenes |
| US7141603B2 (en) | 1999-02-19 | 2006-11-28 | The Regents Of The University California | Antitumor agents |
| US6025328A (en) | 1998-02-20 | 2000-02-15 | The Regents Of The University Of California | Antitumor agents |
| ATE527998T1 (de) | 2005-08-03 | 2011-10-15 | Univ California | Illudin-analoga als krebsmittel |
| US20080065083A1 (en) * | 2006-09-07 | 2008-03-13 | Csaba Truckai | Bone treatment systems and methods |
| WO2015157578A2 (en) | 2014-04-10 | 2015-10-15 | Af Chemicals, Llc | Affinity medicant conjugates |
| US10285955B2 (en) | 2014-04-10 | 2019-05-14 | Af Chemicals, Llc | Affinity medicant conjugate |
| US11135182B2 (en) | 2014-04-10 | 2021-10-05 | Af Chemicals, Llc | Affinity medicant conjugates |
| CN106083953A (zh) * | 2016-06-15 | 2016-11-09 | 成都医学院 | 一种从蕨菜中提取原蕨苷以及制备高纯度原蕨苷的方法 |
| AU2019335222B2 (en) * | 2018-09-04 | 2025-07-03 | Lantern Pharma Inc. | Illudin analogs, uses thereof, and methods for synthesizing the same |
| US11160807B1 (en) | 2018-12-11 | 2021-11-02 | Af Chemicals, Llc | Methods, compositions and devices for treating cancer with illudofulvenes |
| US11591295B2 (en) | 2019-11-25 | 2023-02-28 | Af Chemicals Llc | Affinity illudofulvene conjugates |
| CA3258534A1 (en) * | 2022-06-07 | 2023-12-14 | Lantern Pharma Inc. | CANCER TREATMENT USING COMBINATIONS OF ACYLFULVENS AND IBRUTINIB OR BORTÉZOMIB |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62234040A (ja) * | 1986-04-02 | 1987-10-14 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ１０４３物質 |
-
1990
- 1990-10-02 DK DK90916968.2T patent/DK0565519T3/da active
- 1990-10-02 ES ES90916968T patent/ES2091249T3/es not_active Expired - Lifetime
- 1990-10-02 CA CA002067365A patent/CA2067365C/en not_active Expired - Lifetime
- 1990-10-02 EP EP90916968A patent/EP0565519B1/de not_active Expired - Lifetime
- 1990-10-02 AT AT90916968T patent/ATE141802T1/de not_active IP Right Cessation
- 1990-10-02 DE DE69028320T patent/DE69028320T2/de not_active Expired - Lifetime
- 1990-10-02 IL IL9587590A patent/IL95875A/en not_active IP Right Cessation
- 1990-10-02 JP JP2515522A patent/JPH05503077A/ja active Pending
- 1990-10-02 AU AU67295/90A patent/AU6729590A/en not_active Abandoned
- 1990-10-02 CA CA002530543A patent/CA2530543C/en not_active Expired - Lifetime
- 1990-10-02 WO PCT/US1990/005614 patent/WO1991004754A2/en not_active Ceased
- 1990-10-31 US US07/606,511 patent/US5439942A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2091249T3 (es) | 1996-11-01 |
| WO1991004754A2 (en) | 1991-04-18 |
| US5439942A (en) | 1995-08-08 |
| CA2067365C (en) | 2006-01-31 |
| CA2530543C (en) | 2008-04-01 |
| CA2067365A1 (en) | 1991-04-04 |
| EP0565519A1 (de) | 1993-10-20 |
| DK0565519T3 (da) | 1996-09-23 |
| WO1991004754A3 (en) | 1991-12-12 |
| IL95875A0 (en) | 1991-07-18 |
| EP0565519B1 (de) | 1996-08-28 |
| AU6729590A (en) | 1991-04-28 |
| DE69028320D1 (de) | 1996-10-02 |
| CA2530543A1 (en) | 1991-04-18 |
| IL95875A (en) | 1994-10-21 |
| JPH05503077A (ja) | 1993-05-27 |
| DE69028320T2 (de) | 1997-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE141802T1 (de) | Illudin-analoge, verwendet als antitumormittel | |
| UA29406C2 (uk) | Складні ефіри трициклічних аміноспиртів | |
| DE3750784D1 (de) | Generation eines intrapolierten charakteristischen Wertes zur Anzeige. | |
| ATE151620T1 (de) | Gefässimplantat | |
| ES2139574T3 (es) | Nuevos gases propulsores y su uso en preparaciones medicas. | |
| ATE159428T1 (de) | Enzymatische änderung des haarwuchses | |
| ES2082003T3 (es) | Deshidrodidemnina b. | |
| EP0129778A3 (en) | Cell-stimulating composition | |
| JPS5594337A (en) | Method of improving solubility of active compound having biological activity into water and*or lower aliphatic alcohol and novel compound having improved solubility | |
| ES2161279T3 (es) | Nucleosidos y nucleotidos que contienen racimos de boro. | |
| ES2051650A1 (es) | Procedimiento para preparar un limpiador de oxigeno activo. | |
| AU548324B2 (en) | Biotin antagonist composition for use on skin and hair | |
| GR3004980T3 (de) | ||
| ES2041249T3 (es) | Preparaciones liquidas de 1,2-benzoisotiazolin-3-ona, su obtencion y empleo. | |
| ZA773259B (en) | Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects | |
| JPS57192435A (en) | Modified polypeptide | |
| IL91184A0 (en) | N-2,3-butadienyl tri-and tetraaminoalkane derivatives | |
| CA2061995A1 (en) | Use of oxime ether derivatives for bioregulation in plants | |
| AU4299696A (en) | Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells | |
| ES8600758A1 (es) | Procedimiento para preparar derivados de1,3-dioxolanilo | |
| SE8008189L (sv) | Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa | |
| ES8104188A1 (es) | Un procedimiento para la preparacion de nuevas 3-fenilpropi-laminas n-sustituidas | |
| JPS53113025A (en) | Proliferation inhibitor for microorganisms | |
| ES476837A1 (es) | Procedimientos de preparar derivados pirimidinicos condensa-dos con cabeza de puente de nitrogeno. | |
| AU555285B2 (en) | Gestagenically active 11beta-chloro-delta15-steroids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |